Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface

Retrovirology

Volumn 8, Issue , 2011, Pages

  Marlin, Romain ^a   Nugeyre, Marie Thérèse ^a   Duriez, Marion ^a   Cannou, Claude ^a   Le Breton, Anne ^b   Berkane, Nadia ^c   Barré Sinoussi, Françoise ^a   Menu, Elisabeth ^a  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD14 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CYTOKINE PRODUCTION; DECIDUA; FEMALE; FETOPLACENTAL UNIT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IN VITRO STUDY; INFECTION CONTROL; INNATE IMMUNITY; LEUKOCYTE; MONONUCLEAR CELL; NONHUMAN; SUPERNATANT; UPREGULATION; VERTICAL TRANSMISSION; VIRUS ENTRY; DISEASE TRANSMISSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CYTOKINES; DECIDUA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 79960558434     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-58     Document Type: Article

References (56)

1. Schroder HC, Kelve M, Muller WE. The 2-5A system and HIV infection. Prog Mol Subcell Biol 1994, 14:176-197.
2. Meylan PR, Guatelli JC, Munis JR, Richman DD, Kornbluth RS. Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages. Virology 1993, 193:138-148. 10.1006/viro.1993.1110, 7679856.
3. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815. 10.1126/science.270.5243.1811, 8525373.
4. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877. 10.1126/science.272.5263.872, 8629022.
5. Foli A, Saville MW, Baseler MW, Yarchoan R. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 1995, 85:2114-2123.
6. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990, 172:151-158. 10.1084/jem.172.1.151, 2188185, 2193094.
7. Munoz-Fernandez MA, Navarro J, Garcia A, Punzon C, Fernandez-Cruz E, Fresno M. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation. J Allergy Clin Immunol 1997, 100:838-845. 10.1016/S0091-6749(97)70282-3, 9438495.
8. Makrigiannakis A, Minas V, Kalantaridou SN, Nikas G, Chrousos GP. Hormonal and cytokine regulation of early implantation. Trends Endocrinol Metab 2006, 17:178-185. 10.1016/j.tem.2006.05.001, 16698274.
9. Dubinsky V, Poehlmann TG, Suman P, Gentile T, Markert UR, Gutierrez G. Role of regulatory and angiogenic cytokines in invasion of trophoblastic cells. Am J Reprod Immunol 2009, 63:193-199. 10.1111/j.1600-0897.2009.00778.x, 20047586.
10. von Rango U. Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett 2008, 115:21-32. 10.1016/j.imlet.2007.09.014, 18055021.
11. van't Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994, 94:2060-2067. 10.1172/JCI117560, 294642, 7962552.
12. Ometto L, Zanotto C, Maccabruni A, Caselli D, Truscia D, Giaquinto C, Ruga E, Chieco-Bianchi L, De Rossi A. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 1995, 9:427-434.
13. Salvatori F, Scarlatti G. HIV type 1 chemokine receptor usage in mother-to-child transmission. AIDS Res Hum Retroviruses 2001, 17:925-935. 10.1089/088922201750290041, 11461678.
14. Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Munoz JL. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255:1134-1137. 10.1126/science.1546316, 1546316.
15. Ahmad N, Baroudy BM, Baker RC, Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995, 69:1001-1012. 188669, 7815476.
16. Matala E, Hahn T, Yedavalli VR, Ahmad N. Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission. AIDS Res Hum Retroviruses 2001, 17:1725-1735. 10.1089/08892220152741423, 11788024.
17. Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006, 6:726-732. 10.1016/S1473-3099(06)70629-6, 17067921.
18. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006, 6:584-594. 10.1038/nri1897, 16868549.
19. Williams PL. Fetal membranes and placenta. Gray's anatomy The anatomical basis of medecine and surgery 1995, 158-166. Churchill Livingstone.
20. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens 2004, 63:1-12. 10.1111/j.1399-0039.2004.00170.x, 14651517.
21. Dolcini G, Derrien M, Chaouat G, Barre-Sinoussi F, Menu E. Cell-free HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5. AIDS Res Hum Retroviruses 2003, 19:857-864. 10.1089/088922203322493021, 14585217.
22. Douglas GC, Fry GN, Thirkill T, Holmes E, Hakim H, Jennings M, King BF. Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Res Hum Retroviruses 1991, 7:735-740. 10.1089/aid.1991.7.735, 1742080.
23. Derrien M, Faye A, Dolcini G, Chaouat G, Barre-Sinoussi F, Menu E. Impact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro. J Virol 2005, 79:12304-12310. 10.1128/JVI.79.19.12304-12310.2005, 1211513, 16160157.
24. Marlin R, Nugeyre MT, de Truchis C, Berkane N, Gervaise A, Barre-Sinoussi F, Menu E. Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa. PLoS ONE 2009, 4:e5971. 10.1371/journal.pone.0005971, 2696085, 19543402.
25. von Rango U, Classen-Linke I, Kertschanska S, Kemp B, Beier HM. Effects of trophoblast invasion on the distribution of leukocytes in uterine and tubal implantation sites. Fertil Steril 2001, 76:116-124. 10.1016/S0015-0282(01)01859-3, 11438329.
26. Bulmer JN, Williams PJ, Lash GE. Immune cells in the placental bed. Int J Dev Biol 2010, 54:281-294. 10.1387/ijdb.082763jb, 19876837.
27. King A, Jokhi PP, Smith SK, Sharkey AM, Loke YW. Screening for cytokine mRNA in human villous and extravillous trophoblasts using the reverse-transcriptase polymerase chain reaction (RT-PCR). Cytokine 1995, 7:364-371. 10.1006/cyto.1995.0046, 8589267.
28. Vacca P, Cantoni C, Prato C, Fulcheri E, Moretta A, Moretta L, Mingari MC. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int Immunol 2008,
29. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006, 12:1065-1074. 10.1038/nm1452, 16892062.
30. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 1989, 86:2365-2368. 10.1073/pnas.86.7.2365, 286913, 2784570.
31. Al-Harthi L, Roebuck KA, Landay A. Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol 1998, 18:124-131. 10.1023/A:1023246800353, 9533656.
32. Kollmann TR, Pettoello-Mantovani M, Katopodis NF, Hachamovitch M, Rubinstein A, Kim A, Goldstein H. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. Proc Natl Acad Sci USA 1996, 93:3126-3131. 10.1073/pnas.93.7.3126, 39773, 8610180.
33. Shirazi Y, Pitha PM. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 1993, 193:303-312. 10.1006/viro.1993.1126, 8438572.
34. Faye A, Pornprasert S, Dolcini G, Ave P, Taieb J, Taupin JL, Derrien M, Huerre M, Barre-Sinoussi F, Chaouat G, Menu E. Evaluation of the placental environment with a new in vitro model of histocultures of early and term placentae: determination of cytokine and chemokine expression profiles. Placenta 2005, 26:262-267. 10.1016/j.placenta.2004.08.005, 15708128.
35. Moussa M, Mognetti B, Dubanchet S, Menu E, Roques P, Dormont D, Barre-Sinoussi F, Chaouat G. Expression of beta chemokines in explants and trophoblasts from early and term human placentae. Am J Reprod Immunol 2001, 46:309-317. 10.1034/j.1600-0897.2001.d01-17.x, 11712758.
36. Izcue A, Coombes JL, Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009, 27:313-338. 10.1146/annurev.immunol.021908.132657, 19302043.
37. Swingler S, Mann A, Jacque J, Brichacek B, Sasseville VG, Williams K, Lackner AA, Janoff EN, Wang R, Fisher D, Stevenson M. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 1999, 5:997-103. 10.1038/12433, 10470075.
38. Nilsson J, Kinloch-de-Loes S, Granath A, Sonnerborg A, Goh LE, Andersson J. Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection. Aids 2007, 21:565-574. 10.1097/QAD.0b013e3280117204, 17314518.
39. Casazza JP, Brenchley JM, Hill BJ, Ayana R, Ambrozak D, Roederer M, Douek DC, Betts MR, Koup RA. Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection. PLoS Pathog 2009, 5:e1000646. 10.1371/journal.ppat.1000646, 2763204, 19876388.
40. Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N, Wild CT, Wahl SM. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 2004, 200:1337-1346. 10.1084/jem.20041115, 2211913, 15545357.
41. McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997, 90:1141-1149.
42. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, Wira CR. Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 2009,
43. Furci L, Sironi F, Tolazzi M, Vassena L, Lusso P. Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood 2007, 109:2928-2935.
44. King AE, Critchley HO, Kelly RW. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol Hum Reprod 2000, 6:191-196. 10.1093/molehr/6.2.191, 10655462.
45. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000, 183:1243-1248. 10.1067/mob.2000.107383, 11084573.
46. King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003, 1:116. 10.1186/1477-7827-1-116, 305332, 14641912.
47. Iqbal SM, Ball TB, Levinson P, Maranan L, Jaoko W, Wachihi C, Pak BJ, Podust VN, Broliden K, Hirbod T, et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. Aids 2009, 23:1669-1677. 10.1097/QAD.0b013e32832ea643, 19553806.
48. Pillay K, Coutsoudis A, Agadzi-Naqvi AK, Kuhn L, Coovadia HM, Janoff EN. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 2001, 183:653-656. 10.1086/318535, 11170993.
49. Mselle TF, Howell AL, Ghosh M, Wira CR, Sentman CL. Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12. J Virol 2009, 83:11188-11195. 10.1128/JVI.00562-09, 2772776, 19692460.
50. Dietl J, Honig A, Kammerer U, Rieger L. Natural killer cells and dendritic cells at the human feto-maternal interface: an effective cooperation?. Placenta 2006, 27:341-347. 10.1016/j.placenta.2005.05.001, 16023204.
51. Verma S, Hiby SE, Loke YW, King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 2000, 62:959-968. 10.1095/biolreprod62.4.959, 10727265.
52. Laskarin G, Redzovic A, Rubesa Z, Mantovani A, Allavena P, Haller H, Vlastelic I, Rukavina D. Decidual natural killer cell tuning by autologous dendritic cells. Am J Reprod Immunol 2008, 59:433-445. 10.1111/j.1600-0897.2008.00599.x, 18405314.
53. Akkina RK, Walton RM, Chen ML, Li QX, Planelles V, Chen IS. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 1996, 70:2581-2585. 190105, 8642689.
54. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206:935-944. 10.1006/viro.1995.1016, 7531918.
55. Landau NR, Page KA, Littman DR. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol 1991, 65:162-169. 240501, 1845882.
56. Verrier FC, Charneau P, Altmeyer R, Laurent S, Borman AM, Girard M. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate. Proc Natl Acad Sci USA 1997, 94:9326-9331. 10.1073/pnas.94.17.9326, 23181, 9256481.